Paradigm Medical Industries Developing New Software for P60 UBM Device.

SALT LAKE CITY -- Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, disclosed today it is developing the next generation of Ultrasound software for its P60 Ultrasound BioMicroscope (UBM) through a partnership with Reliacon Global, Inc. (RGI). A prototype of the new software will be available at the upcoming American Society of Cataract and Refractive Surgeons' (ASCRS) Conference in San Diego, beginning April 28, 2007.

"Although we already have exceptional Ultrasound imaging technology, the Company felt there is opportunity for significant improvement through a developmental program with RGI," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "We also believe there is a need to improve our database management system. With the patient record management changes taking place throughout the medical industry, the Company decided to get ahead of the curve and help establish the benchmark for imaging related ophthalmic patient database management."

The P60 UBM is Paradigm Medical's fourth-generation device that is a sophisticated microprocessor-based, multi-frequency Ultrasound BioMicroscope that allows practitioners to acquire and view high-resolution images of the anterior segment of the eye. The P60 is used for imaging of vital structures of the eye, primarily the front half of the eye. Imaging of the anterior chamber angle is one of the principal areas studied in the detection of glaucoma pathologies and related surgical filtering. The P60 UBM has been approved by regulatory agencies in the United States, Canada, Western Europe, Middle East, South America, and most of the Pacific Rim.

Reliacon Global, Inc., is a venture founded by Dr. Bert Massie, former chief executive of Massie Laboratories, Inc. Dr. Massie and his team originally developed the image capture and database management system utilized in the Massie Laboratories RetCam pediatric ophthalmic imaging device.

The new software will be installed in all new P60 UBM's delivered by the Company after July 2007. The new software will also be made available to the current owners of the P60 devices placed into service globally since the P60 was introduced in 2005.

Upon completion of the new P60 software project, RGI will begin redesigning the functionality of the Company's LD400 AutoPerimeter. "Paradigm Medical has been the leader in the field of Kinetic Fixation visual field analysis and will continue to remain in the lead with the anticipated new look and functionality of the LD400," Mr. Cannefax noted. The LD400 AutoPerimeter is used to measure patient visual fields.

Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed "The UBM Company" (Ultrasound BioMicroscope). Contact us at 801-977-8970 or visit us at www.paradigm-medical.com.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.